Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Companies
  3. cancer related gene mutation detection
Show results for
Products
Services
Software
Applications

Companies

News
Articles
Downloads
Videos

Refine by
Locations

  • USA
  • Canada
  • Europe

  • Africa
  • Asia & Middle East
  • Australasia
  • Latin America
  • North America
Business Types

  • Manufacturer
  • Technology
  • Service provider
  • Software vendor
  • Laboratory
Industries served

  • Medical / Health Care
  • Chemical & Pharmaceuticals
  • Monitoring and Testing
  • Health and Safety
Employees

  • 101-1000

Cancer Related Gene Mutation Detection Suppliers & Manufacturers

50 companies found

TransLite LLC

TransLite LLC

based inSugar Land, TEXAS (USA)
TransLite LLC is a small high tech company comprising dedicated people who design, manufacture and sell medical devices that can help reduce the pain and trauma to patients during venous access and treatment of varicose veins. Over 70,000 medical ...
CONTACT SUPPLIER

Mammoth Biosciences, Inc.

Mammoth Biosciences, Inc.

based inBrisbane, CALIFORNIA (USA)
Mammoth Biosciences is harnessing the diversity of nature to power the next generation of CRISPR products. Through its discovery of novel CRISPR systems, the company is enabling the full potential of its platform to read and write the code of life. ...
CONTACT SUPPLIER

Nucleix Ltd.

Nucleix Ltd.

based inSan Diego, CALIFORNIA (USA)
Nucleix is a liquid biopsy company revolutionizing cancer treatment with earlier disease detection, at a time when intervention can bring the greatest impact for patients. Leveraging PCR-based epigenetics, our pioneering testing approach uses ...
Nucleix EpiC - Model Platform - Ultra-Sensitive Liquid-Biopsy Technology

Nucleix EpiC - Model Platform - Ultra-Sensitive Liquid-Biopsy Technology

Liquid biopsies are a new powerful tool in cancer diagnostics that is transforming patient healthcare. Body fluids such as blood or urine are obtained from the patient and analyzed for the presence of circulating tumor DNA which is shed from the ...
CONTACT SUPPLIER

QView Medical

QView Medical

based inLos Altos, CALIFORNIA (USA)
QView Medical, Inc. is a Silicon Valley based private company. The QView team has been the leader in CAD and ABUS development. For over 20 years, members of the team have been involved in obtaining four PMA approvals: R2 mammography CAD, R2 lung CT ...
CONTACT SUPPLIER

Tethis S.p.A

Tethis S.p.A

based inMilan, ITALY
Tethis S.p.A is based in Milan, Italy, and is developing a novel workflow to bring liquid biopsy in the clinical practice for the precise management of cancer. Tethis’ technology points to standardization of the blood sample preparation to provide ...
CONTACT SUPPLIER

Self-screen B.V.

Self-screen B.V.

based inAmsterdam, NETHERLANDS
Self-screen has a long history and track record in translational HPV related science. The company was founded in 2008 to advance the implementation of scientific discoveries in the field of HPV related cancer screening into routine practice. Our ...
The QIAsure - Methylation Test

The QIAsure - Methylation Test

The QIAsure Methylation Test is intended to be used as a triage test for women with a positive HPV DNA test or for women with ASC-US cytology to identify those women who need to be referred for colposcopy. The QIAsure Methylation Test is a multiplex ...
CONTACT SUPPLIER

DermLite LLC

DermLite LLC

based inSan Juan Capistrano, CALIFORNIA (USA)
In late 1999, out of an urge to innovate and excel, John Bottjer, Nizar Mullani, and Thorsten Trotzenberg founded 3Gen as a cutting-edge product design and development company situated in beautiful Orange County, California. At the 2001 meeting of ...
CONTACT SUPPLIER

Micrima Limited

Micrima Limited

based inBristol, UNITED KINGDOM
At Micrima, we are transforming breast tissue analysis to empower earlier, more personalised breast cancer diagnosis. Our innovative Mi~Scan® technology uses safe, harmless radio waves and AI to measure breast tissue properties - quickly, safely, ...
MARIA - Breast Cancer Detection Tool

MARIA - Breast Cancer Detection Tool

Micrima are aiming to open up breast screening to all women. With breast cancer being the most common cancer in women of all ages globally, we believe that all women should be able to have breast screening. The current option for screening is ...
CONTACT SUPPLIER

20/20 GeneSystems Inc.

20/20 GeneSystems Inc.

based inRockville, MARYLAND (USA)
20/20 GeneSystems (“20/20”) is focused on on reducing cancer deaths worldwide through its years of experience in the development and use of cancer biomarker test development. By leveraging this expertise and combining it with advanced machine ...
PAULAs - Blood Test - Early Detection of Lung Cancer

PAULAs - Blood Test - Early Detection of Lung Cancer

20/20 GeneSystems developed PAULA’s Test, a blood test for early detection of lung cancer. It is available in the USA through licensed medical professionals. Testing is performed at 20/20’s CLIA licensed laboratory, Genesys Biolabs (CLIA ...
CONTACT SUPPLIER

Oncimmune Holdings PLC

Oncimmune Holdings PLC

based inNottingham, UNITED KINGDOM
Oncimmune is a leading immuno diagnostics developer, primarily focused on the growing fields of immuno-oncology, autoimmune disease and infectious diseases. Our growing range of diagnostic products can detect early-stage cancer and our service-based ...
Early Detection of Lung Cancer

Early Detection of Lung Cancer

EarlyCDT is a simple blood test that detects the elevated presence of autoantibodies generated by the body's immune system as a natural defence against cancer cells. EarlyCDT Lung is the world’s most thoroughly validated blood test for the ...
CONTACT SUPPLIER

Lightpoint Medical, Ltd

Lightpoint Medical, Ltd

based inWaterside, UNITED KINGDOM
Lightpoint Medical is a technology leader in targeted cancer surgery. We are developing miniaturized imaging and sensing tools for more precise intra-operative cancer detection. Our mission is to improve the lives of people with cancer by ...
Sensei - Model LPH039 V.2 - Advanced Guidance System for Minimally-Invasive Cancer Surgery

Sensei - Model LPH039 V.2 - Advanced Guidance System for Minimally-Invasive Cancer Surgery

Using next-generation miniaturized sensor technology, the SENSEI probe measures just over 40mm in length, enabling unprecedented intracavity maneuverability and anatomic access for surgical ...
CONTACT SUPPLIER

Amadix

Amadix

based inValladolid, SPAIN
Founded in 2010, AMADIX is a leading molecular diagnostics company, focused on liquid biopsy, developing innovative diagnostic tests for early cancer detection in blood. Our mission is to extend people’s lives by developing disruptive technologies ...
PreveCol - Blood Based Test Cutting Edge Liquid Biopsy Technology

PreveCol - Blood Based Test Cutting Edge Liquid Biopsy Technology

PreveCol, an innovative blood-based test for early colorectal cancer detection. PreveCol is an innovative test based on an algorithm that combines the clinical characteristics identified by Artificial Intelligence with the analysis of biomarker ...
CONTACT SUPPLIER

Epigenomics AG

Epigenomics AG

based inBerlin, GERMANY
We revolutionize the way of cancer diagnostics using our unique, proprietary DNA methylation biomarker technology. Epigenomics develops and commercializes patient-friendly, blood-based diagnostic tests across multiple cancer indications with high ...
Epi - Model proColon - Liquid Biopsy Test for The Detection of Colorectal Cancer

Epi - Model proColon - Liquid Biopsy Test for The Detection of Colorectal Cancer

Colorectal cancer is curable in about 90% of cases if detected early. Nevertheless, this disease is one of the most frequent causes of cancer-related deaths in the industrialized world. Regular screening can prevent colorectal cancer. Epi ...
CONTACT SUPPLIER

VisionGate, Inc

VisionGate, Inc

based inPhoenix, ARIZONA (USA)
VisionGate, Inc., is a breakthrough liquid-biopsy technology company, leading the battle against lung cancer through early detection technology with a simple, non-intrusive sputum test. The foundation for our diagnostics capability is the ...
Model LuCED Test - Lung Cell Evaluation Device

Model LuCED Test - Lung Cell Evaluation Device

The LuCED test is a non-intrusive sputum sample that we collect from you and then analyze using our Cell-CT machine. From this sample, LuCED is designed to detect lung cancer early by detecting the abnormal cells. ...
CONTACT SUPPLIER

Hybribio

Hybribio

based inKowloon Bay, HONG KONG
Hybribio, a leader in molecular diagnostic products in China, is engaged in the nucleic acid diagnostic field. It provides a full operation chain from research and development to production and sales. The company's capabilities are enriched by an ...
Hybribio - Stool DNA Methylation Real-time PCR Kit for Colorectal Cancer Detection

Hybribio - Stool DNA Methylation Real-time PCR Kit for Colorectal Cancer Detection

The Stool DNA Methylation Real-time PCR Kit serves as a diagnostic tool for individuals at high risk of colorectal cancer, facilitating in vitro qualitative detection of methylated SDC2 and TFPI2 genes within intestinal exfoliated cells. Designed ...
CONTACT SUPPLIER

QuantView GmbH

QuantView GmbH

based inKiel, GERMANY
QuantView GmbH specializes in advancing MRI technology through revolutionary signal amplification methods, utilizing a quantum mechanical technique for enhanced image resolution. By focusing on hyperpolarized MRI technology, QuantView significantly ...
CONTACT SUPPLIER

Imaging Diagnostic Systems, Inc. (IDSI)

Imaging Diagnostic Systems, Inc. (IDSI)

based inOrlando, FLORIDA (USA)
Imaging Diagnostic Systems, Inc. (IDSI) is a medical device company headquartered in Florida, specializing in the research, development, and marketing of innovative cancer detection systems. Their flagship product, the CTLM system (Computed ...
IDSI - Model CTLM - Laser Computed Tomography Mammography System

IDSI - Model CTLM - Laser Computed Tomography Mammography System

Computed Tomography Laser Mammography (CTLM) is an innovative imaging method focused on visualizing blood distribution within the breast, helpful for identifying breast abnormalities. This technology offers potential advantages in detecting ...
CONTACT SUPPLIER

Grail, Inc.

Grail, Inc.

based inMenlo Park, CALIFORNIA (USA)
We are a healthcare company focused on saving lives and improving health by pioneering new technologies for early cancer detection. We have built a multi-disciplinary organization of scientists, engineers, and physicians and we are using the power ...
Grail - Cancer Detection Technology

Grail - Cancer Detection Technology

GRAIL is poised to detect cancer early by combining high-intensity sequencing of unprecedented breadth and depth with the techniques of modern data science. Through what we believe to be one of the largest clinical study programs ever pursued in ...
CONTACT SUPPLIER

BioMark Diagnostics Inc.

BioMark Diagnostics Inc.

based inRichmond, BRITISH COLUMBIA (CANADA)
BioMark is an oncology-focused company with advanced near-to- market liquid biopsy diagnostic technologies. Our technology improves patient comfort, outcomes and early cancer detection. Biomark owns various intellectual properties, developed for the ...
BioMark - Model SSAT1 - Diagnostics Liquid Biopsy Assay

BioMark - Model SSAT1 - Diagnostics Liquid Biopsy Assay

BioMark’s initial liquid biopsy assay detects SSAT1 using an FDA approved drug. SSAT1 is an enzyme with elevated levels in numerous cancers. The assay targets a well researched and understood metabolic pathway. BioMark of a few unique ...
CONTACT SUPPLIER

Avelas Biosciences

Avelas Biosciences

based inLa Jolla, CALIFORNIA (USA)
Avelas is a clinical-stage drug-device company pioneering the field of fluorescence imaging for real-time cancer detection. Avelas is focused on the development and commercialization of pegloprastide (also referred to as “AVB-620”), a novel ...
Avelas - Model AVB-620 - Pegloprastide - Cell-Penetrating Peptides

Avelas - Model AVB-620 - Pegloprastide - Cell-Penetrating Peptides

Pegloprastide (AVB-620) is based on the science of activatable cell-penetrating peptides and is designed to deliver a fluorescent marker specifically to cancer cells to enable surgeons to identify cancerous tissue in real-time and thus, avoid repeat ...
CONTACT SUPPLIER
  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT